CRISIL Ltd. Valuation Shifts to Very Expensive Amid Mixed Market Returns

Valuation Metrics Reflect Elevated Price Levels

As of 7 August 2026, CRISIL’s P/E ratio stands at 37.59, a significant premium compared to its historical averages and peer group. This level places the stock firmly in the “very expensive” category, a shift from its previous “expensive” rating. The price-to-book value ratio has also surged to 10.16, underscoring the market’s willingness to pay a steep premium for the company’s net asset base.

Other valuation multiples reinforce this elevated pricing stance. The enterprise value to EBITDA (EV/EBITDA) ratio is at 26.57, while the EV to EBIT ratio is 30.23, both well above typical sector averages. These multiples suggest that investors are pricing in robust earnings growth and operational efficiency, despite the premium valuations.

Comparative Analysis with Peers

When benchmarked against key competitors in the capital markets industry, CRISIL’s valuation premium becomes more apparent. CARE Ratings, another major player, is also classified as “very expensive” with a P/E of 30.32 and EV/EBITDA of 25.69, but still trades at a discount to CRISIL’s multiples. ICRA, meanwhile, remains “expensive” but not “very expensive,” with a P/E of 25.24 and EV/EBITDA of 18.32, highlighting a more moderate valuation stance.

This divergence in valuation multiples indicates that CRISIL’s stock price has outpaced its peers, potentially reflecting market expectations of superior growth or quality metrics. However, it also raises concerns about the sustainability of such premiums, especially given the company’s modest PEG ratio of 1.75, which, while below 2, suggests limited margin for error in growth assumptions.

Financial Performance and Quality Metrics

CRISIL’s operational metrics remain strong, with a return on capital employed (ROCE) of 40.16% and return on equity (ROE) of 27.03%. These figures demonstrate efficient capital utilisation and profitability, supporting the premium valuation to some extent. The dividend yield, however, is relatively low at 1.39%, which may deter income-focused investors seeking yield in addition to capital appreciation.

Despite these strengths, the company’s recent market performance has been mixed. Over the past week, CRISIL’s stock price rose by 2.77%, outperforming the Sensex’s 1.32% gain. Over one month, the stock surged 14.55%, vastly outpacing the Sensex’s 0.86% increase. Year-to-date, CRISIL has delivered a positive return of 5.14%, contrasting with the Sensex’s decline of 7.35%. However, over the last year, the stock has underperformed, falling 12.75% compared to the Sensex’s 1.97% loss.

Price Movement and Market Capitalisation Context

CRISIL’s current market price is ₹4,547.65, up 1.71% from the previous close of ₹4,471.00. The stock has traded within a range of ₹4,427.80 to ₹4,570.00 today, remaining below its 52-week high of ₹5,449.95 but comfortably above the 52-week low of ₹3,689.00. The company is classified as a small-cap stock, which may contribute to its valuation volatility relative to larger, more stable capital markets firms.

The stock’s five-year return of 59.54% outpaces the Sensex’s 45.46% gain over the same period, reflecting solid long-term performance. However, the ten-year return of 116.58% trails the Sensex’s 181.19%, indicating that CRISIL has not matched the broader market’s extended growth trajectory. This mixed performance history may influence investor sentiment and valuation expectations going forward.

Implications for Investors

The shift in CRISIL’s valuation grade from “expensive” to “very expensive” signals a heightened risk profile for investors. While the company’s strong ROCE and ROE metrics justify a premium to some extent, the stretched P/E and P/BV ratios suggest that the stock is priced for near-perfect execution and growth. Any deviation from expected earnings growth or market conditions could prompt a sharp re-rating.

Investors should weigh CRISIL’s robust fundamentals against its lofty valuation multiples and consider the broader capital markets environment, which remains susceptible to regulatory changes and economic cycles. The relatively low dividend yield further emphasises the stock’s growth-oriented appeal rather than income generation.

Mojo Score and Rating Update

Reflecting these valuation concerns, CRISIL’s Mojo Score currently stands at 48.0, with a Mojo Grade of “Sell,” downgraded from “Hold” on 6 August 2026. This rating adjustment underscores the cautious stance adopted by analysts, signalling that the stock’s risk-reward profile has deteriorated amid stretched valuations and mixed recent performance.

Given the small-cap status and the premium multiples, investors may prefer to monitor the stock closely for any signs of valuation contraction or earnings disappointment. Alternatively, exploring other capital markets stocks with more attractive valuations and comparable fundamentals could be prudent.

Conclusion

CRISIL Ltd.’s recent valuation re-rating to “very expensive” territory highlights the challenges of investing in a small-cap capital markets firm trading at a premium to peers and historical averages. While the company’s strong profitability metrics and recent outperformance relative to the Sensex provide some support, the elevated P/E and P/BV ratios raise concerns about price sustainability.

Investors should carefully assess whether the current price adequately reflects the risks and growth prospects, especially in a sector prone to cyclical fluctuations. The recent downgrade to a “Sell” rating by MarketsMOJO further emphasises the need for caution and consideration of alternative investment opportunities within the sector.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today